Therapeutic Group: Oncology Presentation Geficent 250: Each tablet contains Gefitinib INN 250 mg. Description Gefitinib is a kinase inhibitor. The epidermal growth factor receptor (EGFR) is expressed on the cell surface of both normal and cancer cells and plays a role in the processes of cell growth and proliferation. Some EGFR activating mutations (exon 19 […]